Prime Medicine and Beam Therapeutics had common origins in gene editing. Now they're both pursuing treatments for the same ...

The funds will facilitate the clinical progression of ABO-101, the company’s lead therapeutic candidate targeting PH1.

Tel Aviv University scientists say that they can inject CRISPR genetic 'molecular scissors' to shrink tumors by 90%; ...

Shares of Prime Medicine ( PRME 13.07%) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m.

The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...

The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...

Researchers are using gene editing techniques to introduce beneficial traits like polled and disease resistance, as well as ...

Shortly after this publication, Bogdanove struck up a collaboration with Daniel Voytas, a plant geneticist at the University ...

An animal geneticist told Kansas cattle producers recently that a gene editing technique is a safe option for shortening the ...

By replacing the defective gene associated with Dravet syndrome in mice, scientists successfully alleviated symptoms without side effects.

The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...

Currently, these technologies are subject to the EU’s strict GMO regulation, making their commercialisation in the bloc ...